It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2010-2011. During the financial year, The Company’s revenue grew by 6% to Rs. 74,693 million or US$ 1.7 billion from Rs. 70,277 million in 2009-10. EBITDA increased by 6% to Rs. 16,789 million in 2010-11 from Rs. 15,828 million in 2009-10. In 2010-11, The Company’s investments in R&D grew by 33% to Rs. 5,060 million. Net profit of Rs. 11,040 million in 2010-11 as against Rs. 1,068 million in 2009-10. Fully diluted earnings per share increased to Rs. 64.95 in 2010-11 from Rs. 6.30 in 2009-10. The paid-up share capital of the Company increased by Rs. 2.04 million in the financial year ended 31st March 2011,
The Board of Directors is pleased to recommend a dividend of Rs. 11.25 per equity share of Rs. 5/- each (@225%) for the financial year 2010-11.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
